跳至主要内容
临床试验/ACTRN12609000860268
ACTRN12609000860268招募中不适用

In neutropenic patients with haematological malignancy, does the use of madu tualang honey lead to less febrile neutropenia compared to oral ciprofloxacin: Open, Randomised, Controlled, Two-Period Cross-Over study

niversiti Sains Malaysia0 个研究点目标入组 135 人开始时间: 2009年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
135

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention

入排标准

年龄范围
12 Years 至 o limit(—)
性别
All

入选标准

  • Confirmed to suffer from blood cancer and Plan to receive at least 2 cycles of same chemotherapy regime.
  • Functional status of European Cooperative Oncology Group (ECOG) score of 3 and better.
  • Consented and signed the consent form.

排除标准

  • history of allergy to ciprofloxacin.
  • history of allergy to honey product.
  • undergoing high dose chemotherapy for stem cell transplantation.
  • serius diabetes requiring intravenous insulin infusion.
  • pregnant or breast-feeding.
  • already ommenced on antibiotics for other than prophylactic indications prior to chemotherapy making the use of ciprofloxacin unnecessary.
  • Impaired renal function (serum creatinine > 300 micromol/L).
  • Impaired liver excretory function (serum bilirubin > 85 micromol/L).
  • Impaired liver cell integrity (alanin transaminase [ALT] > 5x upper limit of normal

研究者

发起方
niversiti Sains Malaysia

相似试验